Search
Selected Filter
Filter Results
Displaying 351–360 of 541 news results
-
Jul 10, 2019
The Foundation’s Contributions to Genetic Research Published in Peer-Reviewed Journal
Research NewsThe nonprofit has emerged as a driving force in genetic research and treatment development for inherited retinal diseases.
-
Jul 9, 2019
SparingVision Gets EU Funding Boost for Development of Cross-Cutting Gene Therapy
Research NewsA clinical trial for the treatment, designed to preserve cone photoreceptors, is planned in the US and Europe in 2020.
-
Jun 17, 2019
The Retina is a Proving Ground for a Broad Range of Neurological Therapies
Research NewsRetinal research paves the way for new treatments for the entire neurological system.
-
Jun 4, 2019
FDA Wins Case against Stem-Cell Clinic that Blinded Patients with Bogus Treatment
Research NewsA federal court ruled that the FDA has regulatory authority over these stem-cell procedures and the power to halt them.
-
Jun 3, 2019
Tackling the Next Gene Therapy Challenge: Autosomal Dominant Diseases
Foundation NewsA discussion of strategies concerning the development of autosomal dominant disease therapies at the Translational Research Acceleration Program (TRAP) in November 2013.
-
May 20, 2019
Dr. Don Zack Honored for Research Contributions by ARVO and the Foundation Fighting Blindness
Research NewsDr. Zack is a member of the Foundation’s Scientific Advisory Board and chairs its Cellular Molecular Mechanisms of Disease study section.
-
May 9, 2019
Research NewsEye Bonds provide the opportunity to advance, and accelerate development for, more promising treatments into and through clinical trials and out to the people who need them.
-
May 9, 2019
Foundation Fighting Blindness Endorses 'Eye Bonds' Legislation
Foundation NewsBipartisan Bill Will Stimulate Up to $1 Billion in New Funding for Blindness Research
-
May 6, 2019
ARVO 2019: Gene Therapy Clinical Trial for RP Caused by RLBP1 Mutations Ongoing in Sweden
Research NewsIn a Novartis lab study, mice with RLBP1 mutations had improved dark adaptation after receiving the gene therapy. The treatment remained effective after one year.
-
May 3, 2019
ARVO 2019: Robot-Assisted Surgery in Clinical Trial for Retinal Disease
Research NewsA video from a clinical trial of robot-assisted surgery demonstrates the potential benefits of robot-assisted subretinal injections.